Biocept, Inc. short interest in 2019
In 2019, Biocept, Inc.'s disclosed short interest ran from 23.97% of shares outstanding on 15 Jan 2019 to 8.92% on 13 Dec 2019, a change of -15.05 percentage points. The year's high was 48.21% on 31 Jan 2019 and its low 2.60% on 13 Sep 2019, averaging 8.92% across 21 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 3.78 days on 29 Nov 2019. Full history: Biocept, Inc..
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023
2019 in figures
- Start of year
- 23.97% (15 Jan 2019)
- End of year
- 8.92% (13 Dec 2019)
- Change
- -15.05 pp
- High
- 48.21% (31 Jan 2019)
- Low
- 2.60% (13 Sep 2019)
- Average
- 8.92%
- Highest days to cover
- 3.78 (29 Nov 2019)
- SEC filings marked
- 8
Every report in 2019
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2019 | 23.97% | 1.00 | |
| 31 Jan 2019 | 48.21% | 1.00 | |
| 15 Mar 2019 | 21.26% | 1.00 | |
| 29 Mar 2019 | 6.03% | 1.00 | 10-K filed, results (8-K) |
| 15 Apr 2019 | 6.64% | 1.26 | |
| 30 Apr 2019 | 4.37% | 1.12 | |
| 15 May 2019 | 5.27% | 1.36 | results (8-K), 10-Q filed |
| 31 May 2019 | 11.83% | 1.00 | |
| 14 Jun 2019 | 4.87% | 1.00 | |
| 28 Jun 2019 | 4.06% | 1.00 | |
| 15 Jul 2019 | 3.71% | 1.63 | |
| 31 Jul 2019 | 3.55% | 1.37 | |
| 15 Aug 2019 | 3.14% | 1.17 | results (8-K), 10-Q filed |
| 30 Aug 2019 | 3.09% | 1.97 | |
| 13 Sep 2019 | 2.60% | 1.73 | |
| 30 Sep 2019 | 2.90% | 2.26 | |
| 15 Oct 2019 | 2.90% | 2.49 | |
| 31 Oct 2019 | 2.80% | 2.42 | |
| 15 Nov 2019 | 7.40% | 2.80 | 10-Q filed, results (8-K) |
| 29 Nov 2019 | 9.70% | 3.78 | |
| 13 Dec 2019 | 8.92% | 1.00 |
See also: Biocept, Inc.'s full history · most shorted US stocks of 2019 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.